Opportunity for Hearing on Proposal to Withdraw 2 ANDA's & 1 AADA | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-1995-N-0166

Opportunity for Hearing on Proposal to Withdraw 2 ANDA's & 1 AADA

Documents

Comments

Description

Docket Status: CLOSED

Comment Period OpensJun 25, 1995

Comment Period ClosesAug 26, 1995

Type	Title	Posted	Comments	Status
Other	Request for Hearing from Kleinfeld, Kaplan and Becker, on behalf of KV Pharmaceutical Co.	Feb 14, 2017	--

CGMP REGULATIONS

DISOPYRAMIDE PHOSPHATE

ETHYLSUCCINATE ORAL SUSPE

ERYTHROMYCIN

PROPOSAL

EXTENDED RELEASE CAPSULES

UNTRUE STATEMENTS

NITROGLYCERIN

HEARING